Surgery for local recurrence after complete response had been obtained by chemoradiotherapy for small cell lung cancer

Kei Miyoshi, Morihito Okada, Miyako Satouchi, Noriaki Tsubota

Research output: Contribution to journalArticle

Abstract

Background. Standard therapy for small cell lung cancer is considered to be chemoradiotherapy, and a role of surgery is limited. Case. A 44-year-old man was admitted with hemoptisis. Since small cell carcinoma of the lung in the right lower lobe was diagnosed, he underwent concurrent chemo-radiotherapy (cisplatin + etoposide + 45 Gy) and additionally 3 courses of chemotherapy (cisplatin + etoposide + irinotecan). Diagnostic imaging indicated a complete response with images, but 20 months later, local recurrence was diagnosed. After 1 course of chemotherapy (cisplatin + irinotecan), complete response was achieved and he has underwent one more course of chemotherapy. Because the disease-free interval was 20 months and his recurrence seemed limited to the original site, he underwent salvage surgery (right middle and lower lobectomy). Viable cancer cells were confirmed in the resected specimen. He is alive without any recurrence four years after surgery. Conclusion. This case makes us reconsider the role of salvage surgery for recurrent small cell lung cancer.

Original languageEnglish
Pages (from-to)151-154
Number of pages4
JournalJapanese Journal of Lung Cancer
Volume46
Issue number2
DOIs
Publication statusPublished - Jan 1 2006
Externally publishedYes

Fingerprint

irinotecan
Small Cell Lung Carcinoma
Chemoradiotherapy
Cisplatin
Recurrence
Etoposide
Drug Therapy
Diagnostic Imaging
Radiotherapy
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Surgery for local recurrence after complete response had been obtained by chemoradiotherapy for small cell lung cancer. / Miyoshi, Kei; Okada, Morihito; Satouchi, Miyako; Tsubota, Noriaki.

In: Japanese Journal of Lung Cancer, Vol. 46, No. 2, 01.01.2006, p. 151-154.

Research output: Contribution to journalArticle

@article{4d6e5ba8e6d84a169b24ba6e8f0ef931,
title = "Surgery for local recurrence after complete response had been obtained by chemoradiotherapy for small cell lung cancer",
abstract = "Background. Standard therapy for small cell lung cancer is considered to be chemoradiotherapy, and a role of surgery is limited. Case. A 44-year-old man was admitted with hemoptisis. Since small cell carcinoma of the lung in the right lower lobe was diagnosed, he underwent concurrent chemo-radiotherapy (cisplatin + etoposide + 45 Gy) and additionally 3 courses of chemotherapy (cisplatin + etoposide + irinotecan). Diagnostic imaging indicated a complete response with images, but 20 months later, local recurrence was diagnosed. After 1 course of chemotherapy (cisplatin + irinotecan), complete response was achieved and he has underwent one more course of chemotherapy. Because the disease-free interval was 20 months and his recurrence seemed limited to the original site, he underwent salvage surgery (right middle and lower lobectomy). Viable cancer cells were confirmed in the resected specimen. He is alive without any recurrence four years after surgery. Conclusion. This case makes us reconsider the role of salvage surgery for recurrent small cell lung cancer.",
author = "Kei Miyoshi and Morihito Okada and Miyako Satouchi and Noriaki Tsubota",
year = "2006",
month = "1",
day = "1",
doi = "10.2482/haigan.46.151",
language = "English",
volume = "46",
pages = "151--154",
journal = "Japanese Journal of Lung Cancer",
issn = "0386-9628",
publisher = "Japan Lung Cancer Society",
number = "2",

}

TY - JOUR

T1 - Surgery for local recurrence after complete response had been obtained by chemoradiotherapy for small cell lung cancer

AU - Miyoshi, Kei

AU - Okada, Morihito

AU - Satouchi, Miyako

AU - Tsubota, Noriaki

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Background. Standard therapy for small cell lung cancer is considered to be chemoradiotherapy, and a role of surgery is limited. Case. A 44-year-old man was admitted with hemoptisis. Since small cell carcinoma of the lung in the right lower lobe was diagnosed, he underwent concurrent chemo-radiotherapy (cisplatin + etoposide + 45 Gy) and additionally 3 courses of chemotherapy (cisplatin + etoposide + irinotecan). Diagnostic imaging indicated a complete response with images, but 20 months later, local recurrence was diagnosed. After 1 course of chemotherapy (cisplatin + irinotecan), complete response was achieved and he has underwent one more course of chemotherapy. Because the disease-free interval was 20 months and his recurrence seemed limited to the original site, he underwent salvage surgery (right middle and lower lobectomy). Viable cancer cells were confirmed in the resected specimen. He is alive without any recurrence four years after surgery. Conclusion. This case makes us reconsider the role of salvage surgery for recurrent small cell lung cancer.

AB - Background. Standard therapy for small cell lung cancer is considered to be chemoradiotherapy, and a role of surgery is limited. Case. A 44-year-old man was admitted with hemoptisis. Since small cell carcinoma of the lung in the right lower lobe was diagnosed, he underwent concurrent chemo-radiotherapy (cisplatin + etoposide + 45 Gy) and additionally 3 courses of chemotherapy (cisplatin + etoposide + irinotecan). Diagnostic imaging indicated a complete response with images, but 20 months later, local recurrence was diagnosed. After 1 course of chemotherapy (cisplatin + irinotecan), complete response was achieved and he has underwent one more course of chemotherapy. Because the disease-free interval was 20 months and his recurrence seemed limited to the original site, he underwent salvage surgery (right middle and lower lobectomy). Viable cancer cells were confirmed in the resected specimen. He is alive without any recurrence four years after surgery. Conclusion. This case makes us reconsider the role of salvage surgery for recurrent small cell lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=33745659847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745659847&partnerID=8YFLogxK

U2 - 10.2482/haigan.46.151

DO - 10.2482/haigan.46.151

M3 - Article

AN - SCOPUS:33745659847

VL - 46

SP - 151

EP - 154

JO - Japanese Journal of Lung Cancer

JF - Japanese Journal of Lung Cancer

SN - 0386-9628

IS - 2

ER -